(Q33401558)

26 July 2017

title

Carboplatin in malignant mesothelioma: a phase II study of the Cancer and Leukemia Group B. (English)

1 reference

26 July 2017

1 reference

N J Vogelzang

1

1 reference

26 July 2017

M Goutsou

2

1 reference

26 July 2017

J M Corson

3

1 reference

26 July 2017

Y Suzuki

4

1 reference

26 July 2017

S Graziano

5

1 reference

26 July 2017

J Aisner

6

1 reference

26 July 2017

M R Cooper

7

1 reference

26 July 2017

K M Coughlin

8

1 reference

26 July 2017

M R Green

9

1 reference

26 July 2017

publication date

1 January 1990

1 reference

Cancer Chemotherapy and Pharmacology

26 July 2017

published in

1 reference

26 July 2017

volume

27

1 reference

26 July 2017

issue

3

1 reference

26 July 2017

page(s)

239-242

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00685720

26 July 2017

exact match

0 references

cites work

Phase II trial of carboplatin (JM8) in treatment of patients with malignant mesothelioma

1 reference

12 December 2020

Phase II trial of high-dose cisplatin in patients with malignant mesothelioma

1 reference

12 December 2020

Malignant pleural mesothelioma: a disease unaffected by current therapeutic maneuvers

1 reference

12 December 2020

High dose carboplatin in the treatment of lung cancer and mesothelioma: a phase I dose escalation study

1 reference

12 December 2020

Malignant mesothelioma. The University of Minnesota experience

1 reference

12 December 2020

A phase I clinical and pharmacokinetic study of carboplatin and autologous bone marrow support

1 reference

12 December 2020

Establishment of human mesothelioma cell lines (MS-1, -2) and production of a monoclonal antibody (anti-MS) with diagnostic and therapeutic potential

1 reference

12 December 2020

Malignant mesothelioma: prognostic variables in a registry of 180 patients, the Dana-Farber Cancer Institute and Brigham and Women's Hospital experience over two decades, 1965-1985

1 reference

12 December 2020

Carboplatin dosage: prospective evaluation of a simple formula based on renal function

1 reference

12 December 2020

Pharmacokinetics and dosage reduction of cis-diammine(1,1-cyclobutanedicarboxylato)platinum in patients with impaired renal function

1 reference

12 December 2020

Confidence limits for probability of response in multistage phase II clinical trials

1 reference

12 December 2020

A phase II study of the platinum analogues JM8 and JM9 in malignant pleural mesothelioma

1 reference

12 December 2020

Phase II trial of mitomycin in malignant mesothelioma

1 reference

12 December 2020

Malignant mesothelioma with occupational and environmental asbestos exposure in an Illinois community hospital

1 reference

12 December 2020

Phase II trial of carboplatin in the management of malignant mesothelioma

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00685720

1 reference

Dimensions Publication ID

26 July 2017

1022406525

0 references

Fatcat ID

release_3dhrxu63pzgf3pnodujf5ykdre

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3dhrxu63pzgf3pnodujf5ykdre

24 November 2022

mapped directly with Wikidata item

1 reference